Cellosaurus logo
expasy logo

Cellosaurus HH-1 (CVCL_B6D4)

[Text version]
Cell line name HH-1
Accession CVCL_B6D4
Resource Identification Initiative To cite this cell line use: HH-1 (RRID:CVCL_B6D4)
Comments Group: Patented cell line.
Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-1811.
Registration: Non-internationally recognized Depositary Authority, Institute for Fermentation, Osaka; IFO50162.
Characteristics: Tridoma obtained by the biological fusion of an hybridoma (AGC-78) with an EBV-transformed LCL cell line.
Monoclonal antibody isotype: IgG2, kappa.
Monoclonal antibody target: Human cancer cell line A431.
Monoclonal antibody target: UniProtKB; P11439; Pseudomonas aeruginosa exotoxin A (eta).
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Hierarchy Parent: CVCL_B6D3 (AGC-78)
Parent: CVCL_B6D1 (PEA7-1-6D)
Category Hybridoma
Publications

PubMed=1369279; DOI=10.1007/BF00148811
Honda S., Ichimori Y., Iwasa S.
A human hybrid hybridoma producing a bispecific monoclonal antibody that can target tumor cells for attack by Pseudomonas aeruginosa exotoxin A.
Cytotechnology 4:59-68(1990)

Patent=EP0336405B1
Iwasa S., Kuriyama M., Okazaki K., Toyoda Y.
Anti-human cancer protein complexes, their production and use.
Patent number EP0336405B1, 13-Jan-1993

Cross-references
Encyclopedic resources Wikidata; Q111733428
Entry history
Entry creation17-Mar-2022
Last entry update21-Mar-2023
Version number3